Dr. Robert Norton Wolfe, MD

Dr. Wolfe practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Wolfe's NPI, 1285726216, was assigned on September 28, 2006. Dr. Wolfe graduated from David Geffen School of Medicine at UCLA in 1975. Dr. Wolfe holds California license G32286.

Dr. Wolfe's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Wolfe's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Wolfe is also affiliated with Cedars-Sinai Marina Hospital. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Wolfe to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wolfe practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Wolfe's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Wolfe is board certified in internal medicine by the American Board of Internal Medicine. Dr. Wolfe is licensed in California.

Dmand AI lists acute sinusitis, asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis and pleural effusion among the conditions Dr. Wolfe treats.

CMS data shows 3,483 Medicare services from Dr. Wolfe across 17 procedure codes in 2024, for 939 Medicare patients. Medicare paid $230,568 for them.

CMS counts 939 Medicare patients who saw Dr. Wolfe in 2024. The largest group is 75 to 84, with 435 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wolfe's median patient age at 78, with 65% women.

In 2024, Dr. Wolfe wrote 5,182 Medicare Part D claims for 832 patients. 48% of them were for generic drugs. CMS names the drug for 4,792 of them, across 65 drugs with 11 or more claims each, at $1,997,898 in total drug cost. In 2023, CMS named 4,876 claims across 67 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Wolfe for performance year 2024, reported as part of a group. Dr. Wolfe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wolfe as offering telehealth.

Dmand AI links Dr. Wolfe to 2 clinical trials. Conditions studied include Asthma, Cataplexy and Narcolepsy. Open Payments lists research payments to Dr. Wolfe that name 1 trial.

CMS Open Payments shows 349 general payments to Dr. Wolfe from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Genentech, Inc. paid the most, $1,454. It also lists 8 research payments totaling $3,385 from 2018 to 2020, naming 1 clinical trial.

Dmand AI lists 6 awards for Dr. Wolfe, most recently America's Top Doctors in 2014.

Dr. Wolfe graduated from David Geffen School of Medicine at UCLA in 1975.

Dr. Wolfe is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.